Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-06-13Clinical Trial Update: Bioequivalence Study of Lamotrigine Tablets 25 mg (2 x 25 mg Tablets) Under Fed Condition [Phase 1]
This document reports the completion of a Phase 1 bioequivalence study of lamotrigine 25 mg tablets under fed conditions conducted by IPCA L…
-
CLINICAL_TRIALS trial_result · 2012-06-13Clinical Trial Update: Bioequivalence Study of Lamotrigine Tablets 25 mg (2 x 25 mg Tablets) Under Fasting Condition [Phase 1]
A Phase 1 bioequivalence study evaluating lamotrigine 25 mg tablets (two 25 mg tablets) under fasting conditions has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-11Clinical Trial Update: Disseminating Evidence-based Mood Disorder Chronic Care Models [NA]
The University of Michigan-sponsored trial has completed and focused on disseminating evidence-based chronic care models for mood disorders,…
-
CLINICAL_TRIALS trial_result · 2012-06-01Clinical Trial Update: To Evaluate the Safety and Metabolic Profile of Vyvanse for the Treatment of ADHD in Euthymic Adults With Bipolar I/II Disorder
This clinical trial update assesses the safety and metabolic profile of lisdexamfetamine (Vyvanse) for treating attention-deficit/hyperactiv…
-
FDA approval · 2012-05-31FDA Approved: LAMOTRIGINE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for lamotrigine from Glenmark Pharmaceuticals Inc., authorizing changes to the approved product.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-05-23Clinical Trial Update: Study of the Clinical Management of Bipolar Disease
AstraZeneca's clinical trial on the clinical management of bipolar disorder has completed, according to the ClinicalTrials.gov update.
-
FDA approval · 2012-05-21FDA Approved: LAMOTRIGINE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved a supplemental application for lamotrigine filed by Unichem Pharmaceuticals (USA), Inc.
-
CLINICAL_TRIALS trial_result · 2012-05-21Clinical Trial Update: Aripiprazole in Children and Adolescents With Bipolar I Disorder [Phase 3]
Phase 3 trial results for aripiprazole in children and adolescents with Bipolar I Disorder have been posted (results posted on 2012-05-21).
-
FDA approval · 2012-05-18FDA Approved: LAMOTRIGINE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approves a supplemental application for Lamotrigine from Alembic Pharmaceuticals Limited, granting approval of a generic lamotrigine pro…
-
CLINICAL_TRIALS trial_result · 2012-05-17Clinical Trial Update: Bipolar Disorder in Epilepsy
Clinical trial investigating bipolar disorder in epilepsy has completed. The study was sponsored by Northwell Health.
-
CLINICAL_TRIALS trial_result · 2012-05-08Clinical Trial Update: Allopurinol for Mania: A Randomized Trial Administering Allopurinol vs. Placebo as add-on to Mood Stabilizers and/or Antipsychotics in Patients in a Bipolar Manic Episode [Phase 3]
A Phase 3 randomized trial evaluated allopurinol as an add-on to mood stabilizers/antipsychotics for mania in bipolar disorder; the study ha…
-
CLINICAL_TRIALS trial_result · 2012-05-01Clinical Trial Update: Effectiveness of Lithium and Valproate in Treating High-Risk Bipolar Disorder [Phase 1]
A Phase 1 study evaluating lithium and valproate for high-risk bipolar disorder has completed.
-
FDA approval · 2012-04-30FDA Approved: RISPERIDONE — Supplemental Application (Amici Pharma, Inc.)
FDA approved a supplemental application for RISPERIDONE from Amici Pharma, Inc.
-
CLINICAL_TRIALS withdrawal · 2012-04-27Clinical Trial Update: Efficacy of Quetiapine XR Versus Divalproex on Clinical Outcome Quality of Sleep and Quality of Life in Bipolar Depression [Phase 4]
A Phase 4 trial comparing quetiapine XR to divalproex for sleep quality and quality of life in bipolar depression has been withdrawn.
-
FDA label_change · 2012-04-26FDA Approved: LATUDA — Supplemental Application (Sumitomo Pharma America, Inc.)
FDA approved a supplemental application for Latuda (lurasidone hydrochloride) filed by Sumitomo Pharma America, Inc., resulting in labeling …
-
CLINICAL_TRIALS trial_result · 2012-04-26Clinical Trial Update: Cognitive-Behavior Therapy for Young Adults With Bipolar Disorder [Phase 1]
Phase 1 clinical trial evaluating cognitive-behavior therapy for young adults with bipolar disorder has been completed.
-
FDA approval · 2012-04-25FDA Approved: LAMOTRIGINE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for lamotrigine by Aurobindo Pharma Limited. This action approves changes to the generic lamotri…
-
FDA approval · 2012-04-23FDA Approved: OLANZAPINE — Original Application (Torrent Pharmaceuticals Limited)
The FDA approved Torrent Pharmaceuticals Limited's original application for a generic olanzapine product, making a generic antipsychotic ava…
-
FDA approval · 2012-04-23FDA Approved: OLANZAPINE — Original Application (Dr. Reddy's Laboratories Ltd.)
FDA approves Dr. Reddy's Laboratories' generic olanzapine under an Original Abbreviated New Drug Application (ANDA).
-
FDA approval · 2012-04-23FDA Approved: OLANZAPINE — Original Application (Dr. Reddy's Laboratories Inc.)
FDA approved Dr. Reddy's Laboratories' original application for olanzapine, enabling a generic version of the antipsychotic.
-
FDA approval · 2012-04-23FDA Approved: OLANZAPINE — Original Application (Aurobindo Pharma Limited)
FDA approved the Original Application for a generic olanzapine product from Aurobindo Pharma Limited.
-
FDA approval · 2012-04-23FDA Approved: OLANZAPINE — Original Application (Apotex Corp.)
The FDA approved Apotex Corp.'s generic olanzapine under an original ANDA. This marks approval of a generic version of olanzapine.
-
CLINICAL_TRIALS trial_result · 2012-04-20Clinical Trial Update: Cytidine and Omega-3 Fatty Acids in Bipolar Disorder [Phase 2]
A Phase 2 clinical trial evaluating cytidine in combination with omega-3 fatty acids for bipolar disorder has completed.
-
CLINICAL_TRIALS trial_result · 2012-04-20Clinical Trial Update: Calling for Care: Cell Phones for Mood Telemetry in Teens [NA]
A completed clinical trial investigating mood telemetry via cell phones in teens with bipolar spectrum disorders, including bipolar disorder…
-
CLINICAL_TRIALS trial_result · 2012-04-19Clinical Trial Update: eCare for Moods: An Internet-based Management Program [NA]
This clinical trial update reports the completion of the eCare for Moods internet-based management program trial for Major Depressive Disord…